CELEGATO, MARTA
CELEGATO, MARTA
Dipartimento di Medicina Molecolare - DMM
A novel small-molecule inhibitor of the human papillomavirus E6-p53 interaction that reactivates p53 function and blocks cancer cells growth
2020 Celegato, M.; Messa, L.; Goracci, L.; Mercorelli, B.; Bertagnin, C.; Spyrakis, F.; Suarez, I.; Cousido-Siah, A.; Trave, G.; Banks, L.; Cruciani, G.; Palu, G.; Loregian, A.
A quantitative LumiFluo assay to test inhibitory compounds blocking p53 degradation induced by human papillomavirus oncoprotein E6 in living cells
2018 Messa, Lorenzo; Celegato, Marta; Bertagnin, Chiara; Mercorelli, Beatrice; Nannetti, Giulio; Palù, Giorgio; Loregian, Arianna
A small molecule targeting the interaction between human papillomavirus E7 oncoprotein and cellular phosphatase PTPN14 exerts antitumoral activity in cervical cancer cells
2023 Bertagnin, C.; Messa, L.; Pavan, M.; Celegato, M.; Sturlese, M.; Mercorelli, B.; Moro, S.; Loregian, A.
ALIX-mediated rescue of feline immunodeficiency virus budding differs from that observed with human immunodeficiency virus
2020 Del Vecchio, C.; Celestino, M.; Celegato, M.; Palu, G.; Parolin, C.; Bouamr, F.; Calistri, A.
Development and validation of a simple and robust HPLC method with UV detection for quantification of the hepatitis C virus inhibitor daclatasvir in human plasma
2017 Nannetti, Giulio; Messa, Lorenzo; Celegato, Marta; Pagni, Silvana; Basso, Monica; Parisi, Saverio G.; Palu', Giorgio; Loregian, Arianna
Discovery of novel SARS-CoV-2 inhibitors targeting the main protease Mpro by virtual screenings and hit optimization
2022 Mercorelli, Beatrice; Desantis, Jenny; Celegato, Marta; Bazzacco, Alessandro; Siragusa, Lydia; Benedetti, Paolo; Eleuteri, Michela; Croci, Federico; Cruciani, Gabriele; Goracci, Laura; Loregian, Arianna
Indomethacin-based PROTACs as pan-coronavirus antiviral agents
2021 Desantis, J.; Mercorelli, B.; Celegato, M.; Croci, F.; Bazzacco, A.; Baroni, M.; Siragusa, L.; Cruciani, G.; Loregian, A.; Goracci, L.
Repurposing the clinically approved calcium antagonist manidipine dihydrochloride as a new early inhibitor of human cytomegalovirus targeting the Immediate-Early 2 (IE2) protein
2018 Mercorelli, Beatrice; Luganini, Anna; Celegato, Marta; Palù, Giorgio; Gribaudo, Giorgio; Loregian, Arianna
Role of the feline immunodeficiency virus L-domain in the presence or absence of Gag processing: involvement of ubiquitin and Nedd4-2s ligase in viral egress
2009 Calistri, Arianna; DEL VECCHIO, Claudia; Salata, Cristiano; Celestino, Michele; Celegato, Marta; Gottlinger, H; Palu', Giorgio; Parolin, MARIA CRISTINA
Small-Molecule Inhibitor of Flaviviral NS3-NS5 Interaction with Broad-Spectrum Activity and Efficacy In Vivo
2023 Celegato, M.; Sturlese, M.; Costa, V. V.; Trevisan, M.; Dias, A. S. L.; Passos, I. B. S.; Queiroz-Junior, C. M.; Messa, L.; Favaro, A.; Moro, S.; Teixeira, M. M.; Loregian, A.; Mercorelli, B.
Targeted disruption of e6/p53 binding exerts broad activity and synergism with paclitaxel and topotecan against hpv-transformed cancer cells
2022 Celegato, M.; Messa, L.; Bertagnin, C.; Mercorelli, B.; Loregian, A.
The antifungal drug isavuconazole inhibits the replication of human cytomegalovirus (HCMV) and acts synergistically with anti-HCMV drugs
2021 Mercorelli, B.; Celegato, M.; Luganini, A.; Gribaudo, G.; Lepesheva, G. I.; Loregian, A.
The Clinically Approved Antifungal Drug Posaconazole Inhibits Human Cytomegalovirus Replication
2020 Mercorelli, Beatrice; Luganini, Anna; Celegato, Marta; Palu', Giorgio; Gribaudo, Giorgio; Lepesheva, Galina I.; Loregian, Arianna
The dimeric form of hpv16 e6 is crucial to drive yap/taz upregulation through the targeting of hscrib
2021 Messa, L.; Celegato, M.; Bertagnin, C.; Mercorelli, B.; Alvisi, G.; Banks, L.; Palu, G.; Loregian, A.